MOESM2 of Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer

Emma Eriksson, Jessica Wenthe, Sandra Irenaeus, Angelica Loskog, Gustav Ullenhag
2016 Figshare  
Additional file 2: Table S1. Patient characteristics.
doi:10.6084/m9.figshare.c.3603950_d1.v1 fatcat:b46q2ogfifflzmhshncsqpk6zy